Detalhe da pesquisa
1.
SARS-CoV-2 causes severe epithelial inflammation and barrier dysfunction.
J Virol
; 95(10)2021 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33637603
2.
STAT1 N-terminal domain discriminatively controls type I and type II IFN signaling.
Cytokine
; 144: 155552, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34000478
3.
Influence of sphingosine-1-phosphate signaling on HCMV replication in human embryonal lung fibroblasts.
Med Microbiol Immunol
; 207(3-4): 227-242, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29700602
4.
Drug resistance of clinical varicella-zoster virus strains confirmed by recombinant thymidine kinase expression and by targeted resistance mutagenesis of a cloned wild-type isolate.
Antimicrob Agents Chemother
; 59(5): 2726-34, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25712361
5.
The anti-obesity drug orlistat reveals anti-viral activity.
Med Microbiol Immunol
; 204(6): 635-45, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25680890
6.
Induction of a broad spectrum of inflammation-related genes by Coxsackievirus B3 requires Interleukin-1 signaling.
Med Microbiol Immunol
; 202(1): 11-23, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22661216
7.
AMPK protects endothelial cells against HSV-1 replication via inhibition of mTORC1 and ACC1.
Microbiol Spectr
; : e0041723, 2023 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37702499
8.
Inhibition of fatty acid synthase by amentoflavone reduces coxsackievirus B3 replication.
Arch Virol
; 157(2): 259-69, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22075919
9.
A viral protein that blocks Arf1-mediated COP-I assembly by inhibiting the guanine nucleotide exchange factor GBF1.
Dev Cell
; 11(2): 191-201, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16890159
10.
Therapy of experimental influenza virus infection with pyrrolidine dithiocarbamate.
Med Microbiol Immunol
; 200(2): 115-26, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21174118
11.
Performance of the RT-LAMP-based eazyplex® SARS-CoV-2 as a novel rapid diagnostic test.
J Clin Virol
; 138: 104817, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33836452
12.
Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage.
Elife
; 102021 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33781385
13.
The PP2A subunit PR130 is a key regulator of cell development and oncogenic transformation.
Biochim Biophys Acta Rev Cancer
; 1874(2): 188453, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33068647
14.
Use of the variplex™ SARS-CoV-2 RT-LAMP as a rapid molecular assay to complement RT-PCR for COVID-19 diagnosis.
J Clin Virol
; 132: 104616, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32891938
15.
The role of sphingosine-1-phosphate signaling in HSV-1-infected human umbilical vein endothelial cells.
Virus Res
; 276: 197835, 2020 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31821843
16.
Recombinant coxsackievirus vectors for prevention and therapy of virus-induced heart disease.
Int J Med Microbiol
; 298(1-2): 127-34, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17897883
17.
Characterization of the protective capability of a recombinant coxsackievirus B3 variant expressing interferon-gamma.
Viral Immunol
; 21(1): 38-48, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18355121
18.
The human fatty acid synthase: a new therapeutic target for coxsackievirus B3-induced diseases?
Antiviral Res
; 76(2): 150-8, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17662476
19.
A severe pediatric infection with a novel enterovirus A71 strain, Thuringia, Germany.
J Clin Virol
; 84: 90-95, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27771495
20.
Interferon-gamma-induced activation of nitric oxide-mediated antiviral activity of macrophages caused by a recombinant coxsackievirus B3.
Viral Immunol
; 18(2): 355-64, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16035947